Crunchyroll is the main global streaming platform for Fire Force Season 3 Part 2 – offering access to the upcoming Fire Force Season 3 Cour 2 episodes right after the Japanese airing. It also offers ...

The Jump Festa 2026 panel for Bleach, which was held on Dec. 21, 2025, revealed that Bleach: Thousand-Year Blood War arc’s final cour, titled The Calamity (Kashintan), will release on July 2026. The ...

A new trailer for the ongoing Tojima Wants to be a Kamen Rider anime series confirms that cour 2 will begin on January 10, 2026 with episode 14. The first cour of Tojima Wants to be a Kamen Rider will ...

Deal values combined firm at $2.5 bln amid sector consolidation Transaction expected to close in second-half of next year Online education stocks lag broader markets on competition woes Udemy ...

Let This Grieving Soul Retire Cour 2 kicked off in early October, and fans are already hooked on Krai's latest misadventures. If you're wondering when the next episode drops or need the full release ...

This repository provides unofficial binary wheels for Pygame for Python on Windows. The files are unofficial (meaning: informal, unrecognized, personal, unsupported, no warranty, no liability, ...

Cour Pharmaceuticals, the Chicago-based clinical-stage biotechnology company, says its first patient has been dosed in the phase 1b/2a clinical trial of a treatment that it hopes will address ...

Soon to be the official tool for managing Python installations on Windows, the new Python Installation Manager picks up where the ‘py’ launcher left off. Python is a first-class citizen on Microsoft ...

Kanishma Ray is a writer at GameRant, who's known to play a mean violin (decently, that is). She's a Computer Science student by day and a wordsmith by night, with a knack for crafting engaging and ...

Andrew Y. Ng, a director at $COUR, sold 25,000 shares of the company on 02-19-2025 for an estimated $206,567. We received data on the trade from a recent SEC filing ...

CHICAGO, Feb. 04, 2025 (GLOBE NEWSWIRE) -- COUR Pharmaceuticals, a clinical-stage biotechnology company developing first-in-class, disease-modifying therapies designed to induce antigen-specific ...

With $720 million in cash, Coursera is well-positioned for potential acquisitions or other strategic uses to spur growth or safeguard against losses. Coursera's growth has slowed, but I believe ...